As of 30 Sep 2025, 5 institutional investors reported holding 14,974 shares of GLOBAL X FDS - GENOMIC BIOTECH (GNOM).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$122,756 | $9.18 | 0 |
| 2025 Q3 | 14,974 | $125,785 | -$12,304,679 | $9.18 | 5 |
| 2025 Q2 | 1,461,926 | $12,323,285 | -$6,993,716 | $8.43 | 50 |
| 2025 Q1 | 2,323,662 | $18,479,579 | -$6,276,333 | $7.95 | 56 |
| 2024 Q4 | 3,090,214 | $30,009,855 | -$1,228,820 | $9.71 | 67 |
| 2024 Q3 | 3,113,307 | $35,023,425 | +$3,006,178 | $11.25 | 61 |
| 2024 Q2 | 2,856,635 | $29,787,474 | -$1,694,380 | $10.44 | 62 |
| 2024 Q1 | 2,708,855 | $30,956,644 | -$5,463,491 | $11.38 | 59 |
| 2023 Q4 | 599 | $6,923 | $11.56 | 1 | |
| 2023 Q3 | 12,177,159 | $123,709,869 | +$16,606,413 | $10.17 | 62 |
| 2023 Q2 | 10,498,009 | $127,244,523 | -$8,426,993 | $12.12 | 61 |
| 2023 Q1 | 11,189,797 | $137,851,961 | +$8,218,967 | $12.32 | 61 |
| 2022 Q4 | 9,503,833 | $120,225,409 | +$628,327 | $12.65 | 61 |
| 2022 Q3 | 10,649,302 | $133,651,633 | +$20,036,772 | $12.55 | 50 |
| 2022 Q2 | 9,026,959 | $110,305,488 | +$55,565,244 | $12.22 | 52 |
| 2022 Q1 | 4,466,420 | $67,117,984 | -$15,572,776 | $15.03 | 56 |
| 2021 Q4 | 5,392,923 | $106,987,811 | -$2,160,710 | $19.85 | 57 |
| 2021 Q3 | 5,461,439 | $121,105,019 | +$42,015,058 | $22.15 | 52 |
| 2021 Q2 | 3,563,450 | $88,236,474 | +$4,129,380 | $24.89 | 44 |
| 2021 Q1 | 3,396,590 | $76,410,188 | +$18,407,204 | $22.48 | 37 |
| 2020 Q4 | 2,531,068 | $59,878,010 | +$9,756,940 | $23.67 | 26 |
| 2020 Q3 | 2,116,135 | $38,049,726 | +$9,088,347 | $17.98 | 18 |
| 2020 Q2 | 1,609,608 | $28,264,975 | +$13,763,569 | $17.56 | 8 |
| 2020 Q1 | 826,002 | $10,451,810 | -$345,919 | $12.46 | 7 |
| 2019 Q4 | 832,618 | $12,997,385 | +$743,973 | $15.61 | 9 |
| 2019 Q3 | 784,934 | $9,810,810 | +$9,421,810 | $12.46 | 5 |
| 2019 Q2 | 26,840 | $415,000 | +$391,001 | $15.38 | 3 |
| 2019 Q1 | 973 | $24,000 | $0 | $24.67 | 1 |